Published in Carcinogenesis on February 01, 2000
Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats. Gut (2001) 1.90
Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus. Gut (2006) 1.58
Nrf2 deficiency impairs the barrier function of mouse oesophageal epithelium. Gut (2013) 1.52
Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis. Neoplasia (2005) 1.38
NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer. Neoplasia (2011) 1.13
Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo. Br J Pharmacol (2013) 1.09
Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus. Nutr Res Rev (2010) 1.05
Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer. Br J Cancer (2007) 1.04
Inflammation and oxidative stress in gastroesophageal reflux disease. J Clin Biochem Nutr (2007) 1.03
Dietary fat and meat intakes and risk of reflux esophagitis, Barrett's esophagus and esophageal adenocarcinoma. Int J Cancer (2011) 0.98
p73 protein regulates DNA damage repair. FASEB J (2011) 0.96
Esophageal adenocarcinoma arising in Barrett esophagus. Cancer Lett (2008) 0.96
Radical decisions in cancer: redox control of cell growth and death. Cancers (Basel) (2012) 0.90
Urinary 8-OHdG: A marker of oxidative stress to DNA and total antioxidant status in essential hypertension with South Indian population. Indian J Clin Biochem (2010) 0.89
Superoxide dismutase prevents development of adenocarcinoma in a rat model of Barrett's esophagus. World J Gastroenterol (2005) 0.88
CDX2 hox gene product in a rat model of esophageal cancer. J Exp Clin Cancer Res (2009) 0.88
Animal Models of Barrett's Esophagus and Esophageal Adenocarcinoma-Past, Present, and Future. Clin Transl Sci (2015) 0.87
A novel external esophageal perfusion model for reflux esophageal injury. Dig Dis Sci (2006) 0.86
Iron intake and markers of iron status and risk of Barrett's esophagus and esophageal adenocarcinoma. Cancer Causes Control (2010) 0.85
Iron intake and body iron stores as risk factors for Barrett's esophagus: a community-based study. Am J Gastroenterol (2008) 0.83
Successful evaluation of a new animal model using mice for esophageal adenocarcinoma. Langenbecks Arch Surg (2010) 0.82
Cigarette smoke induces nuclear translocation of heme oxygenase 1 (HO-1) in prostate cancer cells: nuclear HO-1 promotes vascular endothelial growth factor secretion. Int J Oncol (2013) 0.81
Positive correlation of image analysis by mini-endoscopy with micro-PET scan and histology in rats after esophagoduodenal anastomosis. Surg Endosc (2010) 0.80
Diet composition affects surgery-associated weight loss in rats with a compromised alimentary tract. J Surg Res (2009) 0.79
From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma. World J Gastroenterol (2015) 0.77
Autophagy levels are elevated in barrett's esophagus and promote cell survival from acid and oxidative stress. Mol Carcinog (2015) 0.77
Hemochromatosis gene status as a risk factor for Barrett's esophagus. Dig Dis Sci (2008) 0.76
Etiology and Prevention of Esophageal Cancer. Gastrointest Tumors (2016) 0.75
Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence. Nat Rev Cancer (2017) 0.75
High yield reproducible rat model recapitulating human Barrett's carcinogenesis. World J Gastroenterol (2017) 0.75
Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst (1993) 8.30
Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest (2000) 5.48
Retinylidene proteins: structures and functions from archaea to humans. Annu Rev Cell Dev Biol (2000) 4.01
Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P-450s. Transcriptional and post-transcriptional regulation of the rat enzyme. J Biol Chem (1986) 3.39
Research on esophageal cancer in China: a review. Cancer Res (1980) 3.17
Molecular basis for interactions of G protein betagamma subunits with effectors. Science (1998) 2.88
Lysophospholipids--receptor revelations. Science (2001) 2.61
Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J Cell Biol (1998) 2.54
Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis (1998) 2.27
Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med (2001) 2.26
Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation (1995) 2.24
Assessment of Crohn's disease activity by Doppler sonography of the superior mesenteric artery, clinical evaluation and the Crohn's disease activity index: a prospective study. Clin Radiol (2001) 2.14
Supplementation with vitamins C and E enhances cytokine production by peripheral blood mononuclear cells in healthy adults. Am J Clin Nutr (1996) 2.08
Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1. Mol Biol Cell (1999) 2.02
Percutaneous internal ureteral stent placement: review of technical issues and solutions in 50 consecutive cases. Clin Radiol (1994) 2.01
IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J Immunol (1999) 2.00
Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J Biol Chem (2001) 1.99
Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst (1993) 1.91
Differential coupling of the sphingosine 1-phosphate receptors Edg-1, Edg-3, and H218/Edg-5 to the G(i), G(q), and G(12) families of heterotrimeric G proteins. J Biol Chem (1999) 1.90
Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev (2001) 1.87
Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev (1998) 1.87
Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis. Cancer Res (1993) 1.81
Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology (2000) 1.77
Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells. J Biol Chem (2001) 1.72
Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins. J Biol Chem (2001) 1.70
The CAT-Tox (L) assay: a sensitive and specific measure of stress-induced transcription in transformed human liver cells. Fundam Appl Toxicol (1995) 1.70
Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol Biomarkers Prev (1995) 1.70
Absorption, distribution, elimination of tea polyphenols in rats. Drug Metab Dispos (1997) 1.69
Human ethanol-inducible P450IIE1: complete gene sequence, promoter characterization, chromosome mapping, and cDNA-directed expression. Biochemistry (1988) 1.69
Hepatitis B virus markers in Chinese twins. Anticancer Res (1989) 1.68
Interface ferromagnetism and orbital reconstruction in BiFeO3-La(0.7)Sr(0.3)MnO3 heterostructures. Phys Rev Lett (2010) 1.68
Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol (1993) 1.67
p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res (1994) 1.66
Cardiovascular and Interventional Radiological Society of Europe commentary on the treatment of chronic cerebrospinal venous insufficiency. Cardiovasc Intervent Radiol (2010) 1.66
Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis. Int J Cancer (1994) 1.63
Smoking and mental illness. Pharmacol Biochem Behav (2001) 1.63
Efficacy and safety of the angioseal vascular closure device post antegrade puncture. Cardiovasc Intervent Radiol (2008) 1.61
The use of EUS to diagnose malignant portal venous system invasion by pancreatic cancer. Gastrointest Endosc (1996) 1.59
Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis. Ophthalmology (1998) 1.58
Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol (1998) 1.57
Epstein-Barr virus transcription in nasopharyngeal carcinoma. J Virol (1983) 1.57
Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst (2000) 1.55
Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis (1997) 1.53
The diagnostic accuracy of magnetic resonance cholangiopancreatography and ultrasound compared with direct cholangiography in the detection of choledocholithiasis. Clin Radiol (1999) 1.53
Treatment of continuous data as categoric variables in Obstetrics and Gynecology. Obstet Gynecol (1997) 1.52
Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology (2000) 1.50
Imaging patients with "post-cholecystectomy syndrome": an algorithmic approach. Clin Radiol (2005) 1.50
Primary human herpesvirus 6 infections in children: a prospective serologic study. J Infect Dis (1992) 1.50
DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas. Carcinogenesis (2001) 1.50
Crossing ureteric strictures: microcatheters to the rescue when conventional methods fail. Cardiovasc Intervent Radiol (2007) 1.49
State-of-the-art adrenal imaging. Radiographics (2001) 1.49
LIVER EXTRACT, LIVER ASH AND IRON IN THE TREATMENT OF ANEMIA. J Clin Invest (1930) 1.47
Early surgical débridement of symptomatic pancreatic necrosis is beneficial irrespective of infection. Am J Surg (1992) 1.46
Difference in direct charge-parity violation between charged and neutral B meson decays. Nature (2008) 1.46
Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis (2001) 1.45
Lipoma and liposarcoma: evaluation using CT and MR imaging. AJR Am J Roentgenol (1997) 1.44
Sphingosine-1-phosphate: extracellular mediator or intracellular second messenger? Biochem Pharmacol (1999) 1.44
Interventional radiology of the pleural space. Clin Radiol (1995) 1.44
CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst (1997) 1.43
Metal artifact reduction sequence: early clinical applications. Radiographics (2000) 1.43
Tight clustering of human hepatitis B virus integration sites in hepatomas near a triple-stranded region. J Virol (1987) 1.42
MR imaging features of bizarre parosteal osteochondromatous proliferation of bone (Nora's lesion). Eur J Radiol (2001) 1.38
Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J Pharmacol Exp Ther (1990) 1.38
Hepatic hemangiomas and malignant tumors: improved differentiation with heavily T2-weighted conventional spin-echo MR imaging. Radiology (1994) 1.37
Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem Res Toxicol (1991) 1.37
Occupational exposure to wood, formaldehyde, and solvents and risk of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev (2001) 1.34
Effect of black and green tea polyphenols on c-jun phosphorylation and H(2)O(2) production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction. Carcinogenesis (2000) 1.34
Intestinal permeability correlates with severity of injury in trauma patients. J Trauma (1998) 1.33
Cigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in Taiwan. Cancer Causes Control (1999) 1.32
Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes. Virology (1995) 1.32
Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Res (1997) 1.31
Diagnostic accuracy of magnetic resonance cholangiopancreatography and ultrasound compared with direct cholangiography in the detection of choledocholithiasis. Clin Radiol (2000) 1.31
Rasmussen's aneurysm: a forgotten entity? Cardiovasc Intervent Radiol (2007) 1.29
Somatic mutation of TSSC5, a novel imprinted gene from human chromosome 11p15.5. Cancer Res (1998) 1.29
An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload. Carcinogenesis (1999) 1.29
Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem Res Toxicol (2000) 1.28
Detection of pneumolysin in sputum. J Med Microbiol (1999) 1.27
Inhibitory effect of green tea in the drinking water on tumorigenesis by ultraviolet light and 12-O-tetradecanoylphorbol-13-acetate in the skin of SKH-1 mice. Cancer Res (1992) 1.27
Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Cancer Res (1998) 1.26
Glucosyltransferase gene polymorphism among Streptococcus mutans strains. Infect Immun (1991) 1.26
An improved method for the determination of green and black tea polyphenols in biomatrices by high-performance liquid chromatography with coulometric array detection. Anal Biochem (2000) 1.26
Cholangiographic segmental anatomy of the liver. Radiographics (1994) 1.25
Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. Am J Pathol (1997) 1.24
Tea and tea polyphenols in cancer prevention. J Nutr (2000) 1.23
Imaging of soft tissue infections. Radiol Clin North Am (2001) 1.22
Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved. Cancer Res (1999) 1.22
Role of nitric oxide in acetaminophen-induced hepatotoxicity in the rat. Hepatology (1998) 1.22
Inhibition of glucosyltransferase activities of Streptococcus mutans by a monoclonal antibody to a subsequence peptide. Infect Immun (1993) 1.21
Assessment of breast cancer-related arm lymphedema--comparison of physical measurement methods and self-report. Cancer Invest (2010) 1.20
Vegetable consumption, serum retinol level, and risk of hepatocellular carcinoma. Cancer Res (1995) 1.19
Accuracy of CT in the diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients. AJR Am J Roentgenol (1999) 1.19
Structure-activity relationships of arylalkyl isothiocyanates for the inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism and the modulation of xenobiotic-metabolizing enzymes in rats and mice. Carcinogenesis (1993) 1.18
Measurement of the differential branching fraction and forward-backward asymmetry for B --> K(*)l+l-. Phys Rev Lett (2009) 1.17
Interventional radiology in the diagnosis, management, and follow-up of pseudoaneurysms. Cardiovasc Intervent Radiol (2008) 1.16
Detection of the Staphylococcal mecA gene by chemiluminescent DNA hybridization. J Clin Microbiol (1995) 1.16